💊 Corona Remedies IPO - Key Details
| Detail | Information |
| Company Name | Corona Remedies Limited |
| IPO Open Date | December 8, 2025 (Monday) (Today) |
| IPO Close Date | December 10, 2025 (Wednesday) |
| Price Band | ₹1,008 to ₹1,062 per share |
| Issue Size | ₹655.37 Crores |
| Issue Type | Purely Offer for Sale (OFS) (The company will not receive any proceeds; the money goes to the selling shareholders/promoters). |
| Minimum Lot Size | 14 Shares |
| Minimum Investment (Retail) | ₹14,868 (at the upper price band of ₹1,062) |
| Listing Exchanges | BSE & NSE |
| Expected Listing Date | December 15, 2025 (Tentative) |
📈 Company Profile & Financials
Business: Corona Remedies is an Ahmedabad-based pharmaceutical company that focuses on the domestic Indian market. It develops, manufactures, and markets branded pharmaceutical products across diverse therapeutic areas.
Key Focus Areas: Women's Healthcare, Cardio-Diabeto, Pain Management, and Urology. These are largely chronic/sub-chronic segments, which account for over 70% of its revenue.
Growth: The company has been recognized as one of the fastest-growing companies among the top 30 in the Indian Pharmaceutical Market (IPM) in terms of domestic sales growth.
Financial Snapshot (FY2025):
Revenue: ₹1,202.35 Crores
Profit After Tax (PAT): ₹149.43 Crores
Debt Status: The company has a low Debt/Equity ratio (~0.10) and is considered to be nearly debt-free.
🟢 Grey Market Premium (GMP) Status
As of today, December 8, 2025, the unofficial Grey Market Premium (GMP) for Corona Remedies IPO is reportedly around ₹290 per share.